期刊文献+

高危型HPV检测在宫颈癌筛查中对ASC-US病例的分流作用 被引量:10

Shunting effect of high risk human papillomavirus test in screening of cervical cancer for cases with ASCUS
原文传递
导出
摘要 目的:探讨高危型人乳头瘤病毒(HPV)检测对无明确诊断意义的不典型鳞状上皮细胞(ASC-US)分流监测的临床价值。方法:应用第二代杂交捕获实验(HC-Ⅱ)对261例宫颈细胞学检查结果为ASC-US的患者进行高危型HPVDNA检测,以光镜下病理学诊断作为宫颈上皮内瘤样病变(CIN)的分级标准。结果:261例ASC-US患者CIN检出率为60.92%(159/261),其中高级别CIN16例,检出率为6.13%。261例ASC-US患者高危型HPV DNA检测呈阳性者141例,阳性率为54.02%,高级别CIN中HPV DNA阳性率高达93.75%,高危型HPV阳性组和阴性组ASC-US患者宫颈病变为CINⅡ及其以上病变的检出率分别为11.35%和0.83%,差异具有统计学意义(P<0.01)。结论;ASC-US患者中包括部分高级别病变甚至宫颈癌,并存在相当比例的HPV感染,高危型HPV-DNA检测是一种有效的ASC-US分流管理手段。 Objective:To explore the clinical value of high risk human papillomavirus(HPV) test in shunting monitoring of atypical squamous cell of undetermined significance(ASCUS).Methods:Hybrid capture Ⅱ(HC-Ⅱ) was used for high risk HPV test among 261 cases whose cervical cytological test result was ASCUS;pathological diagnosis under light microscope was used as grading standard of cervical intraepithelial neoplasia(CIN).Results:The detection rate of CIN among 261 cases with ASCUS was 60.92%(159/261),16 cases had CIN of high grades,the detection rate was 6.13 %;141 cases were found with positive high risk HPV,the positive rate was 54.02%,and the positive rate was 93.75% among the cases with CIN of high grades;the detection rates of CIN Ⅱ and CIN Ⅲ in ASCUS cases with positive high risk HPV and negative high risk HPV were 11.35% and 0.83%,respectively,there was significant difference(P〈0.01).Conclusion:ASCUS includes partial CIN of high grades and cervical cancer,and the proportion of HPV infection is large,detection of high risk HPV-DNA is an effective shunting management method of ASCUS.
出处 《中国妇幼保健》 CAS 北大核心 2011年第4期516-518,共3页 Maternal and Child Health Care of China
关键词 高危型人乳头瘤病毒 不典型鳞状细胞 宫颈上皮内瘤样病变 High risk human papillomavirus Atypical squamous cells of undetermined significance Cervical intraepithelial neoplasia
  • 相关文献

参考文献7

  • 1Pagliusi SR, Aguado MT. Efficacy and other milestones for human papillomavirus vaccine introduction[J]. Vaccine, 2004, 23 (5): 569.
  • 2Parkin D, Bray F, Ferlay J, et al. Estimating the world caneer burden: globocan 2000[J] . Int J Cancer, 2001, 94 (2) : 153.
  • 3Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer [ J] . CA Cancer J Clin, 2002, 52 (6): 342.
  • 4Cox JT. Human papillomavirus testing in primary cervical screening and abnormal papanieolaou management [ J] . Obstet Gynecol Surv, 2006, 61 (6): 15.
  • 5Solomon D, Schiffiaan M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. ALTS Study Group [J] .Natl Cancerlnst, 2001, 93 (4) : 293.
  • 6Naucler P, Ryd W, Tomberg S, et al. Human papillomavirus and papanicolaou tests to screen for cervical cancer [ J ] . N Engl J Med, 2007, 357 (16): 1589.
  • 7BoschFX LorinczA MunozN etal.The causal relation between human papillomavirus and cervical cancer .J Clin Pathol,2002,55(4):244-244.

同被引文献63

  • 1单玉珍,马向东,刘明晖,王建.西安市长安区妇科就诊妇女高危型HPV感染及亚型分布调查研究[J].中国现代医药杂志,2012,14(4):38-41. 被引量:15
  • 2谭晓燕,赵静,刘小宁,吴丽容,冯碧清,黄春英.珠海市正常人群妇女宫颈人乳头状瘤病毒感染情况分析[J].中国妇幼保健,2005,20(14):1726-1727. 被引量:22
  • 3任生达,米振国,马俊飞,张永贞,王素梅,孙立新,向喜娥,王全红,石菊芳,乔友林.适宜农村地区子宫颈癌筛查方法的研究[J].肿瘤研究与临床,2005,17(6):391-393. 被引量:21
  • 4岑坚敏,钱德英,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人类乳头瘤病毒检测对不典型鳞状细胞分流监测的临床价值[J].中华妇幼临床医学杂志(电子版),2006,2(1):12-14. 被引量:21
  • 5陈乐真.妇产科诊断病理学[M].2版.北京:人民军医出版社,2010.423.
  • 6Gravitt PE, Paul P, Katki IiA, et al. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a periurban community in Andhra Pradesh, India [J]. PLoS One, 2010, 5(10) :e13711.
  • 7Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update[ J]. Int J Cancer 2007,121 (3) :621 - 32.
  • 8Franz MB,Andreas M,Schiessl B,et al.NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls[J].Acta Ob-stet Gynecol Scand,2009,88(2):234-237.
  • 9Spit zer m,Apgar BS,Brotzman Management of histology cabnormalities of the cervix[j].Am Fam Physician,2006,73(1):105-112.
  • 10Tsuda H,Hashiguchi y,Nishimura S,et al.Relationship between HPV typing and abnormality of G1cell cycle regulators in cervical neop lasm[J].Gynecol Oncol,2003,91(3):476-485.

引证文献10

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部